Flow cytometry susceptibility testing for the antifungal caspofungin

被引:15
|
作者
Mitchell, M [1 ]
Hudspeth, M
Wright, A
机构
[1] Community Med Ctr Fresno, Dept Microbiol, Fresno, CA 93701 USA
[2] Calif State Univ Fresno, Dept Biol, Fresno, CA 93720 USA
关键词
D O I
10.1128/JCM.43.6.2586-2589.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Rapid antifungal susceptibility testing for the antifungal agent caspofungin can be performed using flow cytometry (FC). An FC procedure using acridine orange provided minimum inhibitory concentration (MIC) results within 7 to 9 h which were compared with results obtained using the NCCLS M27-A2 protocol. To evaluate the consistency of this method, susceptibility testing using caspofungin was performed using 73 isolates of eight different species of Candida from various clinical samples in Central California. Macrotiter or microdilution tests were performed according to the NCCLS M27-A2 protocol, and the MICs were compared to those provided by our How cytometry method. All isolates tested had results within the sensitive interpretive category, and 90% of the results compared within I dilution, showing excellent agreement between the methods. The MIC at which 50% of the isolates tested were inhibited (MIC50) and the MIC90 of caspofungin for all eight Candida species were within 1 dilution. This flow cytometer 7-h protocol for testing the antifungal susceptibility of Candida species to caspofungin provided results equivalent to those obtained with the M27-A2 protocol.
引用
收藏
页码:2586 / 2589
页数:4
相关论文
共 50 条
  • [21] Comparison of two probes for testing susceptibilities of pathogenic yeasts to voriconazole, itraconazole, and caspofungin by flow cytometry
    Pina-Vaz, C
    Costa-de-Oliveira, S
    Rodrigues, AG
    Espinel-Ingroff, A
    JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (09) : 4674 - 4679
  • [22] Candida auris susceptibility on surfaces coated with the antifungal drug caspofungin
    Lamont-Friedrich, Stephanie J.
    Kidd, Sarah E.
    Giles, Carla
    Griesser, Hans J.
    Coad, Bryan R.
    MEDICAL MYCOLOGY, 2021, 60 (01)
  • [23] Comparison of susceptibility and transcription profile of the new antifungal hassallidin A with caspofungin
    Neuhof, Torsten
    Seibold, Michael
    Thewes, Sascha
    Laue, Michael
    han, Cg-Ok Han
    Hube, Bernhard
    von Doehren, Hans
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 349 (02) : 740 - 749
  • [24] Flow cytometry antifungal susceptibility testing of pathogenic yeasts other than Candida albicans and comparison with the NCCLS broth microdilution test
    Ramani, R
    Chaturvedi, V
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (10) : 2752 - 2758
  • [25] ANTIBIOTIC SUSCEPTIBILITY TESTING OF CANDIDA-ALBICANS BY FLOW-CYTOMETRY
    PORE, RS
    CURRENT MICROBIOLOGY, 1990, 20 (05) : 323 - 328
  • [26] Rapid susceptibility testing of fungi by flow cytometry using vital staining
    Wenisch, C
    Linnau, KF
    Parschalk, B
    ZedtwitzLiebenstein, K
    Georgopoulos, A
    JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (01) : 5 - 10
  • [27] ANTIFUNGAL SUSCEPTIBILITY TESTING WITH DERMATOPHYTES
    GEORGII, A
    KORTING, HC
    MYCOSES, 1991, 34 (5-6) : 193 - 199
  • [28] Standardization of antifungal susceptibility testing
    Cormican, MG
    Pfaller, MA
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (04) : 561 - 578
  • [29] Antifungal Susceptibility Testing and Identification
    Kidd, Sarah E.
    Crawford, Lucy C.
    Halliday, Catriona L.
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2021, 35 (02) : 313 - 339
  • [30] Antifungal drug susceptibility testing
    Warnock, DW
    Johnson, EM
    CURRENT OPINION IN INFECTIOUS DISEASES, 1997, 10 (06) : 444 - 448